Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional)
ID: 354812Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354812

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-25-002.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Jun 7, 2024 12:00 AM
  4. 4
    Due Aug 6, 2024 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional)". This grant aims to support research on Fragile X and FMR1-associated conditions, focusing on understanding the factors underlying the variability in clinical features among affected individuals. The grant encourages multidisciplinary teams of investigators to apply precision medicine approaches to address the proposed overarching theme. The research should aim to broaden our understanding of the phenotypic heterogeneity and/or variability in response to interventions seen in one or more FMR1 associated conditions. The grant does not require cost sharing or matching and falls under the category of Income Security and Social Services. The eligibility criteria include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs), among others. The deadline for applications is August 6, 2024. For more information and to apply, visit the NIH grants website at http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-25-002.html.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
RFA-HD-25-002-Full-Announcement.html
6/08/2024
Similar Opportunities
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional). This grant program aims to support research centers that conduct drug abuse and addiction research in any area of NIDA's mission. The centers should have outstanding innovative science, be multidisciplinary, thematically integrated, synergistic, and serve as national resources to provide educational and outreach activities to drug abuse research communities, educational organizations, the general public, and policy makers in the NIDA research fields. The goal of this program is to create NIDA Centers that are national community resources for furthering drug abuse research. The centers are expected to foster the career development and mentoring of new investigators and provide them with meaningful roles to play in the center projects. The centers should also share their findings, data, and resources with researchers to use and build upon, advancing research in the field of drug abuse. The grant does not require cost sharing or matching requirements. The funding instrument type is a grant, and the category of funding activity is health. The opportunity is posted on grants.gov and falls under the discretionary category. The CFDA number associated with this grant is 93.279. The eligible applicants for this grant include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the federal government, faith-based or community-based organizations, Hispanic-serving institutions, historically Black colleges and universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. territories or possessions. Non-domestic (non-U.S.) entities (foreign organizations) and non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. The closing date for this grant opportunity is November 18, 2025. For more information and to apply, please visit the following link: [NIDA Research Center of Excellence Grant Program](http://grants.nih.gov/grants/guide/pa-files/PAR-23-076.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIDCD Clinical Research Center Grant, which aims to advance the diagnosis, prevention, treatment, and amelioration of human communication disorders. This grant is specifically focused on research involving individuals with communication disorders or data/tissues from individuals with a communication disorder. The research can cover a wide range of areas, including hearing, balance, smell, taste, voice, speech, or language. Applicants may propose a clinical trial, but it is optional. The grant does not require cost sharing or matching requirements. The eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs). Non-domestic (non-U.S.) entities and components are not eligible to apply. The grant opportunity is currently open and the deadline for submission is October 9, 2024. For more information and to apply, visit the following link: [NIDCD Clinical Research Center Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-22-025.html). For any inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)". This grant aims to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The objective of this grant is to advance and improve the diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research. Special emphasis will be placed on the early and timely identification of individuals with rare diseases and clinical trial readiness. The grant does not require cost sharing or matching requirements and falls under the category of Income Security and Social Services. The maximum award ceiling is $1,000,000. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are also not eligible to apply. The grant opportunity will close on August 13, 2024, and the archive date is set for September 18, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-206.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-206.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)". This grant aims to encourage research using novel behavioral measures to advance precision assessment, prognosis, and treatment of mental disorders. The focus of this grant is to develop or optimize behavioral tasks that measure individual differences and demonstrate added utility for clinical prediction when combined with standard clinical diagnosis. Additionally, the grant aims to form a data infrastructure that can support computational approaches to build tools for clinical decision making. The maximum award ceiling for this grant is $2,500,000. Eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for application submission is October 18, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-195.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-195.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)". This grant falls under the category of Income Security and Social Services. The purpose of this funding opportunity is to provide investigators with access to resources provided by the Data Management Coordinating Center for Diagnostic Centers of Excellence. These resources include infrastructure, data management, and clinical research support for a new network of clinical sites that provide diagnostic services for patients with undiagnosed diseases. The grant does not require cost sharing or matching. The eligible applicants for this grant include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are also not eligible to apply. The closing date for this grant is May 15, 2025. For more information and to apply, please visit the following link: [Diagnostic Centers of Excellence Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-171.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.